Designing Growth Strategies is in our DNA

Oral Biologics Drugs Market Size, Share & Industry Analysis, By Drug Class (GLP-1 Receptor Agonists, Dual Incretin Agonists, Somatostatin Analogs, Insulins, Growth Hormone & Analogs, Parathyroid Hormone Analogs, & Others), By Disease Indication (Type 2 Diabetes, Obesity / Weight Management, Acromegaly / Pituitary Disorders, Osteoporosis / Bone Metabolism Disorders, & Others), By Product Type (Tablets, Capsules, Oral Solution/Syrup, Oral Powder/Granules, Orodispersible Film/Tablet, & Others), By Age Group (Pediatric & Adults), By Distribution Channel, and Regional Forecast, 2026-2034

Last Updated :July 20, 2026 | Format:PDF | Report ID: 115769

 

Speak to Analyst

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 190